Spots Global Cancer Trial Database for recurrent adult soft tissue sarcoma
Every month we try and update this database with for recurrent adult soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery | NCT01206140 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | Laboratory Biom... Selumetinib Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00052754 | Sarcoma | gefitinib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | NCT00005874 | Gastrointestina... Sarcoma Small Intestine... | rubitecan | - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma | NCT00004123 | Sarcoma | Doxorubicin hyd... Conventional su... Intraoperative ... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma | NCT01222715 | Adult Rhabdomyo... Childhood Alveo... Childhood Pleom... Childhood Rhabd... Previously Trea... Recurrent Adult... Recurrent Child... | Bevacizumab Cyclophosphamid... Laboratory Biom... Temsirolimus Vinorelbine Tar... | - 29 Years | National Cancer Institute (NCI) | |
| Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | NCT01281865 | Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ... | diagnostic labo... everolimus imatinib mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas | NCT00217620 | Sarcoma | sorafenib | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | NCT01281865 | Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ... | diagnostic labo... everolimus imatinib mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas | NCT01782313 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | tivozanib laboratory biom... | 18 Years - | Northwestern University | |
| Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | NCT00064220 | Sarcoma | soblidotin | 15 Years - | Daiichi Sankyo | |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | NCT00006357 | Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | imatinib mesyla... | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 | NCT01430637 | Sarcoma | DNA analysis RNA analysis gene expression... mutation analys... nucleic acid se... polymerase chai... laboratory biom... pharmacogenomic... | - 50 Years | Children's Oncology Group | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas | NCT01782313 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | tivozanib laboratory biom... | 18 Years - | Northwestern University | |
| Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma | NCT02849366 | Recurrent Adult... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma | NCT01016015 | Metastatic Oste... Recurrent Adult... Recurrent Osteo... Stage III Adult... Stage IV Adult ... | Cixutumumab Laboratory Biom... Temsirolimus | 16 Years - | National Cancer Institute (NCI) | |
| BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00022542 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | NCT00053794 | Endometrial Can... Sarcoma | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00104949 | Sarcoma | trastuzumab | 18 Years - | National Cancer Institute (NCI) | |
| Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery | NCT00098579 | Gastrointestina... Recurrent Adult... Stage IV Adult ... | alvocidib doxorubicin hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma | NCT01462630 | Adult Angiosarc... Recurrent Adult... Stage III Adult... Stage IV Adult ... | pazopanib hydro... laboratory biom... positron emissi... computed tomogr... fludeoxyglucose... | 18 Years - | Fox Chase Cancer Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Bevacizumab in Treating Patients With Angiosarcoma | NCT00288015 | Sarcoma | Bevacizumab | 18 Years - | Northwestern University | |
| Chemotherapy in Treating Patients With Advanced Sarcoma | NCT00002526 | Ovarian Cancer Sarcoma | filgrastim doxorubicin hyd... ifosfamide | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00017446 | Sarcoma | CP4071 | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | NCT00005874 | Gastrointestina... Sarcoma Small Intestine... | rubitecan | - | National Cancer Institute (NCI) | |
| Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma | NCT02048722 | Adult Angiosarc... Recurrent Adult... Stage III Adult... Stage IV Adult ... | regorafenib | 18 Years - | Northwestern University | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Rosiglitazone in Treating Patients With Liposarcoma | NCT00004180 | Sarcoma | rosiglitazone m... | 18 Years - | Dana-Farber Cancer Institute | |
| Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma | NCT00027911 | Sarcoma | NY-ESO-1 peptid... sargramostim | 18 Years - | Columbia University | |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma | NCT00233948 | Adult Liposarco... Recurrent Adult... Stage III Adult... Stage IV Adult ... | nelfinavir mesy... biopsy laboratory biom... pharmacological... gene expression... western blottin... reverse transcr... immunoenzyme te... | 18 Years - | City of Hope Medical Center | |
| Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma | NCT00017030 | Sarcoma | trabectedin | 18 Years - | National Cancer Institute (NCI) | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma | NCT00919269 | Adult Rhabdomyo... Childhood Desmo... Chordoma Desmoid-Type Fi... Metastatic Chil... Non-Metastatic ... Previously Trea... Recurrent Adult... Recurrent Child... Recurrent Child... Rhabdomyosarcom... Stage I Adult S... Stage II Adult ... Stage III Adult... Stage IV Adult ... Untreated Child... | Cytology Specim... Laboratory Biom... | - 50 Years | Children's Oncology Group | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma | NCT00085475 | Sarcoma | imatinib mesyla... conventional su... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00004109 | Sarcoma | Doxorubicin Hyd... Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00937495 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | vorinostat bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00083213 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00041249 | Gastrointestina... Sarcoma | brostallicin | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma | NCT01653028 | Myxofibrosarcom... Recurrent Adult... Recurrent Leiom... Recurrent Lipos... Recurrent Malig... Recurrent Undif... Stage III Soft ... Stage IV Soft T... | Alisertib Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans | NCT00084630 | Adult Fibrosarc... Dermatofibrosar... Recurrent Adult... Stage IV Adult ... | imatinib mesyla... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma | NCT00005628 | Sarcoma | vitespen | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas | NCT00217620 | Sarcoma | sorafenib | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma | NCT00033709 | Sarcoma | temozolomide thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor | NCT00068367 | Sarcoma | erlotinib hydro... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery | NCT01206140 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | Laboratory Biom... Selumetinib Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab in Treating Patients With Angiosarcoma | NCT00288015 | Sarcoma | Bevacizumab | 18 Years - | Northwestern University | |
| Troglitazone in Treating Patients With Liposarcoma | NCT00003058 | Sarcoma | troglitazone | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00937495 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | vorinostat bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma | NCT01462630 | Adult Angiosarc... Recurrent Adult... Stage III Adult... Stage IV Adult ... | pazopanib hydro... laboratory biom... positron emissi... computed tomogr... fludeoxyglucose... | 18 Years - | Fox Chase Cancer Center | |
| Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery | NCT00217607 | Sarcoma | paclitaxel | 18 Years - 70 Years | UNICANCER | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma | NCT00423618 | Sarcoma | radiotherapy | 16 Years - 120 Years | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma | NCT00740597 | Sarcoma | gene expression... polymerase chai... western blottin... neoadjuvant the... therapeutic con... intensity-modul... | 18 Years - | City of Hope Medical Center | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | NCT00410462 | Ovarian Cancer Sarcoma Small Intestine... | brostallicin doxorubicin hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma | NCT00052390 | Sarcoma | bevacizumab doxorubicin hyd... | 18 Years - | National Cancer Institute (NCI) | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00017446 | Sarcoma | CP4071 | 18 Years - | National Cancer Institute (NCI) | |
| Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma | NCT02048722 | Adult Angiosarc... Recurrent Adult... Stage III Adult... Stage IV Adult ... | regorafenib | 18 Years - | Northwestern University | |
| Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall | NCT00089544 | Recurrent Adult... Stage I Adult S... Stage II Adult ... Stage III Adult... | Dacarbazine Doxorubicin Hyd... Filgrastim Ifosfamide Laboratory Biom... Radiation Thera... Thalidomide Therapeutic Con... | 16 Years - | National Cancer Institute (NCI) | |
| Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma | NCT00003719 | Sarcoma | irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00052754 | Sarcoma | gefitinib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
